Stakeholder Perspective The Clinical and Economic Complexity of Biologics

被引：0
|
作者：
Vogenberg, F. Randy [1 ,2 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Sch, Dept Hlth Policy, Philadelphia, PA 19107 USA
[2] Pharmaceut Strategies LLC, Black Hawk, CO 80422 USA
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2008年 / 1卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Biologics in the Treatment of Psoriasis: Clinical and Economic Overview
    Poulin, Yves
    Langley, Richard
    Teixeira, Henrigue D.
    Martel, Marie-Josee
    Cheung, Sun
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 : S49 - S57
  • [2] Is a transdisciplinary perspective on economic complexity possible?
    Rosser, J. Barkley, Jr.
    [J]. JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2010, 75 (01) : 3 - 11
  • [3] Managing stakeholder communication during a construction crisis - from the perspective of complexity
    Ying, Zhong
    Pheng, Low Sui
    [J]. PROCEEDINGS OF CRIOCM 2008 INTERNATIONAL RESEARCH SYMPOSIUM ON ADVANCES OF CONSTRUCTION MANAGEMENT AND REAL ESTATE, 2008, : 315 - 320
  • [4] Unpacking the complexity of the UK plastic packaging value chain: A stakeholder perspective
    Gerassimidou, Spyridoula
    Lovat, Elena
    Ebner, Norman
    You, Weimu
    Giakoumis, Theodoros
    Martin, Olwenn, V
    Iacovidou, Eleni
    [J]. SUSTAINABLE PRODUCTION AND CONSUMPTION, 2022, 30 : 657 - 673
  • [5] The complexity of biodiversity: A biological perspective on economic valuation
    Farnsworth, K. D.
    Adenuga, A. H.
    de Groot, R. S.
    [J]. ECOLOGICAL ECONOMICS, 2015, 120 : 350 - 354
  • [6] Economic complexity and health outcomes: A global perspective
    Vu, Trung V.
    [J]. SOCIAL SCIENCE & MEDICINE, 2020, 265
  • [7] Update on Biosimilars - Complexity of Biologics and Clinical Concerns: Importance of Proper Evaluation
    Lee, V. W. Y.
    [J]. HONG KONG JOURNAL OF RADIOLOGY, 2012, 15 (04): : S72 - S74
  • [8] Biologics Economic Impact of the Change of Biologics
    Fietz, Cornelia
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2019, 24 (06): : 267 - +
  • [9] Use of biologics in SLE: a review of the evidence from a clinical perspective
    Aytan, Jayoti
    Bukhari, Marwan A. S.
    [J]. RHEUMATOLOGY, 2016, 55 (05) : 775 - 779
  • [10] Stakeholder Perspective
    Piper, Kip
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2008, 1 (07): : 26 - 26
12345